{"id":"https://openalex.org/W185335681","doi":null,"title":"Design and Synthesis of H3 Receptor Inverse Agonists with AchE Inhibitor Activity and QSAR Study of H3 Receptor Antagonists","display_name":"Design and Synthesis of H3 Receptor Inverse Agonists with AchE Inhibitor Activity and QSAR Study of H3 Receptor Antagonists","publication_year":2009,"publication_date":"2009-05-31","ids":{"openalex":"https://openalex.org/W185335681","mag":"185335681"},"language":"en","primary_location":{"id":"mag:185335681","doi":null,"is_oa":false,"landing_page_url":"http://ethesis.nitrkl.ac.in/1406/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015324331","display_name":"Akalabya Bissoyi","orcid":"https://orcid.org/0000-0002-0909-8556","observed_orcids":["https://orcid.org/0000-0002-0909-8556"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Akalabya Bissoyi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0909-8556","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5015324331"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9384999871253967,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9384999871253967,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.05790000036358833,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histamine-h3-receptor","display_name":"histamine H3 receptor","score":0.9390000104904175},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.9259999990463257},{"id":"https://openalex.org/keywords/inverse-agonists","display_name":"inverse agonists","score":0.7289999723434448},{"id":"https://openalex.org/keywords/hybrid-molecules","display_name":"hybrid molecules","score":0.5820000171661377},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9010000228881836},{"id":"https://openalex.org/keywords/pharmacophore-identification","display_name":"pharmacophore identification","score":0.7210000157356262},{"id":"https://openalex.org/keywords/2d-qsar","display_name":"2D-QSAR","score":0.8420000076293945},{"id":"https://openalex.org/keywords/3d-qsar","display_name":"3D-QSAR","score":0.9990000128746033},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.847000002861023},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.9760000109672546},{"id":"https://openalex.org/keywords/bovine-rhodopsin","display_name":"bovine rhodopsin","score":0.7179999947547913}],"concepts":[{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.8670244216918945},{"id":"https://openalex.org/C63180777","wikidata":"https://www.wikidata.org/wiki/Q288395","display_name":"Histamine H3 receptor","level":4,"score":0.745934247970581},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.6099982261657715},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5447181463241577},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.476139098405838},{"id":"https://openalex.org/C2778501154","wikidata":"https://www.wikidata.org/wiki/Q18349602","display_name":"Histaminergic","level":3,"score":0.4454452097415924},{"id":"https://openalex.org/C69366308","wikidata":"https://www.wikidata.org/wiki/Q2272286","display_name":"ADME","level":3,"score":0.4394034147262573},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3218376934528351},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.31223732233047485},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.2597854733467102},{"id":"https://openalex.org/C1122143","wikidata":"https://www.wikidata.org/wiki/Q61233","display_name":"Histamine","level":2,"score":0.258761465549469},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24159649014472961},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.23345914483070374},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19979625940322876},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.16903716325759888}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:185335681","doi":null,"is_oa":false,"landing_page_url":"http://ethesis.nitrkl.ac.in/1406/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1548843388","https://openalex.org/W1971761527","https://openalex.org/W1980240737","https://openalex.org/W2027271443","https://openalex.org/W2049902088","https://openalex.org/W2060809301"],"related_works":["https://openalex.org/W2181674998","https://openalex.org/W2027271443","https://openalex.org/W2053989377","https://openalex.org/W4323315556","https://openalex.org/W3080978714","https://openalex.org/W2035431239","https://openalex.org/W2339472709","https://openalex.org/W2982348439","https://openalex.org/W2026581284","https://openalex.org/W2981185189"],"abstract_inverted_index":{"Currently,":[0],"acetyl":[1,93],"cholinesterase":[2,94],"and":[3,54,59,142,166,196,223],"N-methyl-D-aspartate":[4],"antagonists":[5,40],"are":[6,41],"commercially":[7],"available":[8,27,143],"for":[9,43,154,173],"the":[10,23,30,44,63,69,73,76,83,132,152,178,181,191],"treatment":[11,45],"of":[12,17,26,33,46,65,78,102,138,146,169,193,199,246],"Alzheimer's":[13],"disease":[14,111],"(AD).":[15],"Approach":[16],"using":[18,243],"multifunctional":[19],"inhibitors":[20,61],"to":[21,108,150],"reduce":[22],"side":[24],"effects":[25,116],"drugs":[28,103],"is":[29,85],"main":[31],"objective":[32],"this":[34],"work.":[35],"Presently,":[36],"Histamine-3":[37],"(H3)":[38],"receptor":[39,175,195,249],"used":[42,107,149],"several":[47],"neurodegenerative":[48],"disorders":[49],"such":[50],"as":[51,98],"Epilepsy,":[52],"Alzheimer\u2018s":[53,110],"Parkinson\u2018s":[55],"diseases.":[56],"Both":[57],"H3":[58,139,174,194,224,248],"AchE":[60,120,147,200,222],"cure":[62],"symptoms":[64],"Alzheimer":[66],"by":[67,118,234],"enhancing":[68],"acetylcholine":[70],"levels":[71],"in":[72,81,220,239],"brain.":[74],"But":[75],"mechanism":[77],"action":[79],"involved":[80],"both":[82,221],"cases":[84],"different.":[86],"Here,":[87],"we":[88],"propose":[89],"histamine-3":[90],"antagonist":[91],"with":[92,112],"(AchE)":[95],"inhibitor":[96],"activity":[97],"a":[99],"novel":[100],"class":[101],"which":[104],"can":[105,125],"be":[106,126],"treat":[109],"less":[113],"adverse":[114],"peripheral":[115],"caused":[117],"excessive":[119],"inhibitor.":[121],"Our":[122],"present":[123],"study":[124,168],"divided":[127],"into":[128],"two":[129],"parts.":[130],"In":[131,180],"first":[133],"part,":[134,183],"homology":[135],"modeled":[136],"structure":[137,145],"active":[140],"site":[141],"crystal":[144],"was":[148,214,231],"collect":[151],"information":[153],"pharmacophore":[155,192,198],"identification.":[156],"The":[157,211,226],"important":[158],"descriptors":[159],"were":[160,187,206],"identified":[161],"based":[162,189,251],"on":[163,190,252],"comparative":[164],"2D-QSAR":[165],"3D-QSAR":[167],"28":[170],"druggable":[171],"compounds":[172],"collected":[176],"from":[177],"literature.":[179],"second":[182],"five":[184,203],"hybrid":[185,204,212,228],"molecules":[186,205],"generated":[188],"known":[197],"inhibitors.":[201],"All":[202],"screened":[207],"through":[208,216],"ADME/tox":[209],"filters.":[210],"molecule":[213],"validated":[215],"GOLD":[217],"docking":[218],"score":[219],"receptor.":[225],"best":[227],"compound":[229],"(hybrid-3)":[230],"then":[232],"evaluated":[233],"molecular":[235],"dynamics":[236],"(MD)":[237],"simulation":[238],"water":[240],"solvent":[241],"model":[242,245],"3D":[244],"human":[247],"(build":[250],"bovine":[253],"rhodopsin":[254],"structure).":[255]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}